Pricing Log in Create free account

Estrella Immunopharma, Inc. (ESLA) vs Polyrizon Ltd. (PLRZ)

Estrella Immunopharma, Inc. and Polyrizon Ltd. are both Biotechnology companies. Estrella Immunopharma, Inc. and Polyrizon Ltd. are of similar size ($23.7M and $23.3M). Across the 6 metrics below, Polyrizon Ltd. leads on 4 and Estrella Immunopharma, Inc. on 2.

Valuation

Metric ESLA PLRZ Biotechnology median
P/E n/m — 8.50
P/S n/m — 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (56.72%) — (33.15%)
Free cash flow yield (50.75%) 0.00% (25.50%)

Profitability

Metric ESLA PLRZ Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 148.05% 0.00% (56.36%)
Return on assets (416.74%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ESLA PLRZ Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (188.78%) 99.37% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ESLA PLRZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.20 36.37 4.72
Net debt to EBITDA 0.11 2.11 0.96

Dividend

Metric ESLA PLRZ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ESLA PLRZ Biotechnology median
Market cap 23.28m 23.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack